Latest oppositions filed by Mathys & Squire Llp

This table presents recent patent oppositions filed by Mathys & Squire Llp against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3088900Troponin As Marker For Intermittent Atrial FibrillationF. HOFFMANN-LA ROCHE AGMay 12, 2021
EP3134551Compositions And Methods For Enhancing And/Or Predicting Dna AmplificationENVIROLOGIX INC.Mar 3, 2021
EP3416493Consumable EmulsionSYMRISE AGDec 22, 2020
EP2909232Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)Dec 11, 2020
EP2917736Tnt Based Diagnosis Of Paroxysmal Atrial FibrillationF. HOFFMANN-LA ROCHE AGSep 25, 2020
EP1827604Methods And Compositions For Adoptive ImmunotherapyPETER MACCALLUM CANCER INSTITUTEAug 20, 2020
EP2349332Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6THE GENERAL HOSPITAL CORPORATIONJul 23, 2020
EP3011032Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic CellsMASSACHUSETTS INSTITUTE OF TECHNOLOGYJul 16, 2020
EP2928496Crispr-Based Genome Modification And RegulationSIGMA-ALDRICH CO. LLCJul 9, 2020
EP3360964Crispr-Based Genome Modification And RegulationSIGMA-ALDRICH CO. LLCJul 2, 2020